Scott Nelson's videos and podcasts
September 2026
I might start using this line when meetings start dragging, too! David Allen, the guy behind “Getti...
“Whatever clinical evidence you generated for clearance is by no means equivalent to the evidence re...
One question Paul Coletta asks every potential candidate at Vero Bioscience, Inc.: “Why Vero?” It’s...
🎙️ In this interview with Paul Coletta, co-founder and CEO of Vero Bioscience, Inc., he shares lesso...
Vero is solving for the "what next" dynamic that often gets missed in consumer healthcare. Paul Col...
A few years ago, I published this article with MD+DI about what it really takes to develop and comme...
The post below reminded me of our early days at Joovv. In the dead of a Minneapolis winter in 2015,...
The cheese in the mousetrap. Hits hard, but so true. For CEOs who are heads-down raising capital, I...
At a large strategic, a broad portfolio serves as a backstop. If one product misses, another can pot...
August 2026
The thing about building in a regulated space like healthcare is that by the time everyone hears abo...
If you’re entering an established market, leading with better technology is rarely enough. Durable ...
If you’ve listened to any of my interviews with startup CEOs, you’ve probably heard me say that buil...
SetPoint Medical made a critical decision to build its reimbursement function in-house. On a recent...
Throwback to a piece I shared with MD+DI on expanding commercial reach in medtech when the market is...
In the Medsider interview below, Tim Gleeson also gave us the lowdown on his previous startup, Novas...
If you work in medtech, or really anywhere in healthcare, things often feel a bit too buttoned up. ...
If you work in medtech, or really anywhere in healthcare, things often feel a bit too buttoned up. ...
When you're launching an implantable device, it's easy to think the surgeon or interventionalist sho...
When you're launching an implantable device, it's easy to think the surgeon or interventionalist sho...
July 2026
Often, the answer to “Why not sooner?” is something like: “This is how long it usually takes” or “Th...
I asked Vijit Sabnis, co-founder & CEO of Adaptyx Biosciences, what made him decide this was the ide...
There are a lot of days when I feel completely stuck. Especially when you’re dealing with challenges...
When starting your fundraising journey, the first decision shouldn’t be how much money to raise. Ins...
Throwback to an article I wrote a couple of years ago for MD+DI. The landscape hasn’t dramatically ...